CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops advanced optical imaging systems to improve the characterization of tumor tissues and spheroids for cancer treatment testing. By enabling non-destructive analysis, it aims to enhance personalized medicine approaches for drug-resistant cancers like glioblastoma.
Drug resistance, whether intrinsic or acquired during the course of treatment, is the primary cause of cancer treatment failure.
Resistance is a complex and highly personalized problem, depending on tumor-specific, genetic, and other factors, but certain cancers are particularly difficult to treat.
In particular, the most common and deadliest type of cancer originating in the brain, glioblastoma (GBM), is aggressive and highly resistant to treatment.
Due to the complex nature of GBM, advanced me…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
